| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |